Edition:
United Kingdom

People: Gimv Investeringsmaatschappij Voor Vlanderen NV (GIMV.BR)

GIMV.BR on Brussels Stock Exchange

53.30EUR
20 Aug 2019
Change (% chg)

€-0.10 (-0.19%)
Prev Close
€53.40
Open
€53.40
Day's High
€53.40
Day's Low
€53.20
Volume
419
Avg. Vol
13,837
52-wk High
€56.50
52-wk Low
€45.50

Vermeersch, An 

Ms. An Vermeersch has been Non-Executive Independent Director of GIMV NV since June 2017. She graduated as a Bio-Engineer in Microbiology and Biochemistry from the University of Ghent and obtained an MBA from the Vlerick Business School. She started her career at GSK, after which she moved to McKinsey & Company Inc as a consultant in 2000, where she led several projects in Healthcare and Pharma. In 2008, she returned to GSK Vaccines as Global Business Operations Director - Global Vaccines Development. From 2012 to 2015, as Vice President - Vaccines Executive Office, she led the drafting of a new strategy, the transformation programme and the integration of Novartis Vaccines. She was appointed Vice President - Global Health and Public Affairs in 2016 and, among other things, directs the Global Health strategy. In 2018, she also became responsible for Global Governmental Affairs at GSK Vaccines.

Basic Compensation

Total Annual Compensation, EUR 32,250
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 32,250

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --